Start exploring your own markets for free

🚀 Try for Free

AI Therapeutics

Light Search completed
Invite
Radar Tracking

Subspaces (4)

Drug Discovery Optimization
Biomarker Identification
Genomic Data Analysis
Drug Repurposing

Pending to review

Not sure yet

Interested

Not interested

Download list

Showing 104 results
Company
Fit assessment
Description
Subspaces
Tags
HQ Location
Founding Date
Employees
Total Funding Raised
Last Funding Event
Received on
Vium

Vium leverages machine learning to discover patterns and identify biomarkers, facilitating the advancement of new therapeutics in preclinical research.

Provider of digital biomarkers intended to assist in pre-clinical drug research. The company's biomarkers are derived from artificial intelligence, machine learning and sensor technology and assists in accelerating the pre-clinical drug discovery and development pipeline, enabling researchers and drug developers to obtain improved insights into disease progression and take better decisions on which compounds should be advanced to the clinic.
  • Biomarker Identification
Light Search
United States201351 - 200$53.94MAcquired by Recursion Pharmaceuticals, July 2020
Oct 14, 2024
USC Big Data Health Science Center

The USC Big Data Health Science Center leverages machine learning for innovative research, discovering patterns and expanding therapeutic approaches, while also focusing on biomarker identification.

The University of South Carolina (USC) Big Data Health Science Center (BDHSC), an interdisciplinary enterprise and one of the USC Excellence Initiatives established in 2019, promotes and supports big data health science research through capacity development, academic training, professional development, community engagement, and methodological advancement. Its five content cores (Artificial Intelligence for Sensing and Diagnosis, Electronic Health Records, Genomics, Geospatial, and Social Media) and two functional hubs (Business/Entrepreneurship and Technology) embody interdisciplinary collaboration and foster cutting-edge research and discovery. Our mission is to be an innovation-driven enterprise that can facilitate and accelerate a sustained, high-caliber transformation of the USC into a global leader in big data health science.
  • Biomarker Identification
Light Search
United States11 - 50NA
Oct 14, 2024
MNM Bioscience Inc.

MNM leverages machine learning for pattern discovery and the development of new therapeutics, while also focusing on biomarker identification to enhance personalized medicine.

MNM is a scientific start-up created by an interdisciplinary group of enthusiasts. We are a multi-specialist team of experts from geneticists, to molecular biologists, bioinformaticians and AI specialists. We combine next-generation AI with the most advanced genomic approaches (whole genome and multiomics data) to save the lives of cancer patients through predictive modeling and drug target identification.
  • Biomarker Identification
Light Search
Cambridge (United States)201833$3.29MSeed, $2.44M, October 20, 2020
Oct 14, 2024
Bioada

Bioada leverages machine learning for pattern discovery and aims to expand therapeutics through innovative biomarker and drug discovery solutions.

Developer of AI-powered biomarker and drug discovery solutions designed to revolutionize EMR software and unlock new frontiers in biomarker and drug discovery. The company offers AI-powered biomarker and drug discovery solutions, enabling customers to make breakthroughs in biomarker and drug discovery that were once thought to be impossible.
  • Biomarker Identification
Light Search
Canada20211 - 10NA
Oct 14, 2024
Intelligent OMICS

Intelligent OMICS leverages machine learning to discover patterns and expand therapeutic options, while also identifying biomarkers for personalized medicine.

Developer of an automated drug discovery platform designed to identify new drugs and companion diagnostics. The company's platform uses artificial intelligence to model molecular data, discerning the underlying disease pathway for each disease that helps to predict pre-clinical tox effects, saving up pre-clinical development costs and reducing the need for animal trials, enabling pharma and biotech companies to discover novel targets and to accelerate programs through to IND.
  • Biomarker Identification
Light Search
Nottingham (United Kingdom)20091 - 10NA
Oct 14, 2024
OntoChem

OntoChem leverages machine learning and pattern discovery to enhance therapeutic development and identify biomarkers, showcasing their innovative approach in the life sciences.

Developer of tools and algorithms designed to provide added value to customers by helping them to navigate the complex information world. The company's tools and algorithms develop individual or industrial-scale cognitive computing solutions to perform customized indexing of intranet and internet data, enabling clients to apply semantic search solutions for pharmaceutical, material sciences, and technology-driven businesses.
  • Biomarker Identification
Light Search
Germany200511 - 50Acquired by Digital Science, June 2023
Oct 14, 2024
Pheiron

Pheiron leverages machine learning to discover patterns and develop targeted therapeutics, while also focusing on biomarker identification for personalized medicine.

Developer of a phenotyping platform intended to decode disease to advance new therapies. The company's platform generates digital biomarkers for the interpretation of biomedical data, transforms complex biomedical data into actionable insights, and drug development for rare diseases, enabling clients to get drugs for different targeted diseases.
  • Biomarker Identification
Light Search
Berlin (Germany)20231 - 10NA
Oct 14, 2024
Imvaria

IMVARIA leverages machine learning to enhance patient outcomes through novel pattern discovery and the expansion of therapeutics, focusing on digital biomarker identification.

Developer of a digital biomarker designed to enhance patient outcomes. The company's digital biomarkers use modern computer science techniques for solving complex and serious clinical problems and provide non-invasive diagnostic and therapeutic patient stratification via data science and machine learning decision-making, enabling clinicians to make the best decisions.
  • Biomarker Identification
Light Search
United States201911 - 50Seed, April 30, 2020
Oct 14, 2024
PromiseBio

The company effectively leverages machine learning for biomarker discovery and therapeutic expansion, demonstrating a strong fit in the healthcare innovation space.

Operator of an artificial intelligence-based healthcare platform intended to treat lingering diseases. The company specializes in harnessing complex artificial intelligence biomarker discovery technology to optimize personalized treatment plans and facilitate quality of care, enabling patients to get affordable treatment for chronic diseases and improve their health.
  • Biomarker Identification
Light Search
United States20231 - 10$8.30MSeed, $8.30M, April 1, 2023
Oct 14, 2024
Talon Biomarkers

Talon Biomarkers leverages machine learning for data analysis, discovers patterns in immune cell responses, and enhances therapeutic strategies through biomarker identification.

Developer of a biomarker discovery engine designed for precision medicine and immunotherapy success. The company's services include consultation and support, data analytics, immune profiling, and biomarker discovery services, thereby providing comprehensive immune analysis services and delivering insights that advance understanding and transform patient care.
  • Biomarker Identification
Light Search
United States20211 - 10NA
Oct 14, 2024